A Randomized, Double Blind , Placebo Controlled Trial to Compare the Effect of Tiotropium [Spiriva] Inhalation Capsules on Exercise Tolerance in Patients With COPD [chronic obstructive pulmonary disease] Participating in 8 Weeks of Pulmonary Rehabilitation
Phase of Trial: Phase III
Latest Information Update: 30 Dec 2017
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 20 Dec 2007 Status changed from in progress to completed.
- 10 Aug 2006 Status change
- 30 Oct 2005 New trial record.